Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000727014 | SCV000534368 | likely benign | not provided | 2021-09-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001079496 | SCV000557877 | benign | Hypertrophic cardiomyopathy 14 | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000727014 | SCV000704929 | uncertain significance | not provided | 2017-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000617875 | SCV000736044 | likely benign | Cardiovascular phenotype | 2023-11-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000423727 | SCV001519617 | benign | not specified | 2021-03-13 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001798780 | SCV002043201 | benign | Cardiomyopathy | 2019-09-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000727014 | SCV004129057 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | MYH6: BP4, BP7, BS1 |
Diagnostic Laboratory, |
RCV000727014 | SCV001739858 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000423727 | SCV001921832 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000423727 | SCV001931445 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000423727 | SCV001953021 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000727014 | SCV001975340 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004544553 | SCV004799199 | benign | MYH6-related disorder | 2019-05-02 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |